Kimberly-Clark Stock News

I'm talking about the cash I have sitting here that I desperately want to get into the market. Earlier this year, I got a chunk of money from selling a house.

Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion ​bid for Tylenol maker Kenvue , a filing ‌on the European Commission website showed on Wednesday.

Kimberly-Clark is readying concessions to address ​EU antitrust concerns about ‌its bid for Tylenol maker Kenvue that could help ​it win approval ​for the $40 billion deal after ⁠a preliminary review, ​people familiar with the matter ​said.

Owning consumer staples stocks is an absolute must in a dividend investing strategy. Most people turn to dividend stocks for two reasons — to generate income or to put the magic of compounding to work using dividend reinvestment to amplify wealth building over time.

Huggies renames its nano and micro preemie diapers "Huggies Little Fighters" and marks NICU Awareness Month by spotlighting real stories and supporting families CHICAGO, Sept. 3, 2026 /PRNewswire/ -- This NICU Awareness Month, Huggies® is rallying families, caregivers and communities to recognize the extraordinary strength of babies in the NICU, and the people fighting alongside them.

Australia's competition regulator on Wednesday approved Kimberly-Clark's proposed $40 billion takeover of Kenvue , ​on condition the company divests Kenvue's Carefree ‌and Stayfree period care brands in the country to address competition concerns.

Kimberly-Clark has asked EU regulators permission ​for its proposed $40 billion takeover ‌of Tylenol maker Kenvue, documents on the EU ​Commission's website showed.

So far investors have been focused on artificial-intelligence infrastructure plays rather than productivity beneficiaries, says Goldman Sachs.